I am responsible for the development and application of technologies in the area of precise genome engineering, human stem cell based disease models and transgenics in Discovery Sciences at Astrazeneca and the facilitating the exploitation of these technologies by our iMED disease focus areas for their drug discovery activities. I previously worked for many years at the Wellcome Trust Sanger Institute where I was involved in the generation of the large scale targeted mouse knockout resources of the IKMC and the IMPC and the generation of bespoke mouse and human stem cell models.
There are two parts to the World Advanced Therapies & Regenerative Medicine Congress: a conference and an exhibition featuring solutions for pharma and biotech.
There is a registration fee to attend the conferences. To visit the exhibition is free.